Apdua, Samantha Jean V.

HRN: 27-87-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2025
CEFUROXIME 750MG (VIAL)
10/01/2025
10/08/2025
IVT
185mg
IVT
URTI; T/C Typhoid Fever
Rejected 

 Indication:  Empiric    Type of Infection:  URTIBloodstream    Compliance to guidelines: Non-compliant To Guidelines